CMS Reimbursement Shift in Prostate Cancer: Streamlining Radiotracer Payments

Author(s):

David Albala, MD, discusses how starting October 1st, CMS will reimburse imaging centers directly, simplifying the process and removing reimbursement concerns for physicians ordering radiotracer tests.

EP: 1.An Overview of PSMA-PET Scans and Prostate Cancer Imaging

EP: 2.Advancements in Prostate Cancer Imaging: The Evolution of PET Scans

EP: 3.Prostate Cancer Imaging: PSMA Agents and Radiotracer Options

EP: 4.Challenges and Progress in Advanced Imaging for Prostate Cancer

Now Viewing

EP: 5.CMS Reimbursement Shift in Prostate Cancer: Streamlining Radiotracer Payments

EP: 6.Prostate Cancer Imaging and Care in 2023: Best Practices

EP: 7.Practical Guidance for Prostate Cancer Imaging: PSMA-PET Scans and Patient Selection

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!

Related Content

July 19th 2021

UroView: The Role of Liquid Biomarkers for Early Detection of Prostate Cancer

David Albala, MD Judd W. Moul, MD

This article features insights from David Albala, MD, and Judd W. Moul, MD, on using liquid biomarker-based testing for the early detection of prostate cancer.

May 27th 2021

UroView: Gallium 68 PSMA–Targeted PET Imaging in Prostate Cancer: Staging and Outcomes

Phillip Kuo, MD, PhD Andre L. Abreu, MD

This article features insights from Phillip Kuo, MD, PhD, and Andre Abreu, MD, on gallium 68 PSMA-targeted PET imaging in prostate cancer.

May 17th 2021

UroView: The Importance of Image Quality in the Urological Workflow

This article features insights from a urology expert, Bradley Schwartz, DO, FACS, on the importance of image quality and radiation safety.